期刊文献+

大剂量甲氨蝶呤不同给药持续时间治疗原发性中枢神经系统淋巴瘤的研究 被引量:2

Study on the Treatment of Primary Central Nervous System Lymphoma with Different Infusion Duration of High-Dosage of Methotrexate
下载PDF
导出
摘要 目的研究大剂量甲氨蝶呤(HD-MTX)不同给药持续时间治疗原发性中枢神经系统淋巴瘤对患者脑脊液中药物浓度的影响。方法采用自身对照法比较HD-MTX快速滴注(3 h)与常规滴注(6 h)对患者脑脊液中MTX浓度的影响;利用反相高效液相色谱法检测MTX浓度;对不同测量时间点两种给药方式的脑脊液药物浓度进行配对t检验,分析脑脊液药物浓度与血药浓度的相关性。结果HD-MTX快速滴注(3 h)与常规滴注(6 h)给药后第3 h(6.56μmol·L-1 vs.4.40μmol·L-1,P=0.017)、6 h(7.53μmol·L-1 vs.5.03μmol·L-1,P<0.001)、12 h(2.27μmol·L-1 vs.0.63μmol·L-1,P=0.005),患者脑脊液中的药物浓度有显著差异;常规滴注后第12 h,患者脑脊液中的MTX浓度(0.63±0.33)μmol·L-1低于有效治疗浓度,而快速滴注后12 h的浓度(2.27±0.70)μmol·L-1仍维持在有效治疗浓度;患者血药浓度与脑脊液药物浓度无明显相关性(r=0.221)。结论HD-MTX快速滴注(3 h)相比常规滴注(6 h)可显著提高原发性中枢神经系统淋巴瘤患者脑脊液中的MTX浓度,延长药物有效作用时间,且患者耐受良好。 Objective To study the effect of high dosage of methotrexate(HD-MTX)infusion duration on the concentration of drug in the cerebrospinal fluid(CSF)of the patients with primary central nervous system diffuse large B-cell lymphoma.Methods The self-contrast method was employed to compare the influence of HD-MTX rapid infusion(3 h)and regular infusion(6 h)on the concentration of MTX in CSF.The MTX drug concentration was measured by reversed-phase high-performance liquid chromatography.Paired t-test was performed on cerebrospinal fluid drug concentrations in two treatment cycles at different measurement time points,in order to analyze the correlation between the MTX concentration in CSF and that in blood.Results There were significant differences in the MTX concentration in CSF between the ways of rapid infusion(3 h)and regular infusion(6 h)at 3 h(6.56μmol·L-1 vs.4.40μmol·L-1,P=0.017),6 h(7.53μmol·L-1 vs.5.03μmol·L-1,P<0.001),and 12 h(2.27μmol·L-1 vs.0.63μmol·L-1,P=0.005)after the completion of infusion duration of HD-MTX.The concentration of MTX in CSF at 12 h[(2.27±0.70)μmol·L-1]after the rapid infusion still hold the therapeutic effect.However,it was lower than the effective therapeutic concentration at 12 h[(0.63±0.33)μmol·L-1]after regular infusion.The MTX plasma concentration had no significant correlation with the MTX concentration in CSF(r=0.221).Conclusion Compared with the regular infusion(6 h),rapid infusion(3 h)increased the MTX concentration in CSF and prolonged the effective time of MTX,and both regimens were well tolerated.
作者 周倩倩 易平勇 易嘉宁 ZHOU Qianqian;YI Pingyong;YI Jianing(Second Department of Oncology,Hunan Provincial People’s Hospital/First Affiliated Hospital of Hunan Normal University,Changsha,Hunan,410000,China;Department of Oncology,Changsha Kexin Cancer Hospital,Changsha,Hunan,410006,China;Department of Breast and Thyroid Surgical,Hunan Provincial People’s Hospital/First Affiliated Hospital of Hunan Normal University,Changsha,Hunan,410000,China)
出处 《肿瘤药学》 CAS 2020年第4期467-471,496,共6页 Anti-Tumor Pharmacy
关键词 原发性中枢神经系统淋巴瘤 甲氨蝶呤 给药持续时间 Primary central nervous system lymphoma Methotrexate Infusion duration
  • 相关文献

参考文献3

二级参考文献27

  • 1湛洁谊,叶铁真,吴梓梁,陈福雄,邹亚伟,王波.大剂量甲氨蝶呤治疗急性淋巴细胞白血病[J].实用儿科临床杂志,2005,20(7):652-654. 被引量:15
  • 2薛惠良,汤静燕,陈静,潘慈,陈静,叶辉,王耀平,顾龙君.儿童急性淋巴细胞性白血病中枢神经系统浸润的防治[J].中国实用儿科杂志,2005,20(11):683-684. 被引量:6
  • 3Borsi J D, Schuler D, Moe P J. Methotrexate administered by 6-h and 24-h infusion: a pharmacokinetic comparison [J]. Cancer Chemother Pharmacol, 1988,22( 1 ) : 33-35.
  • 4Tetef M L, Margolin K A, Doroshow J H, et al. Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosis [J]. Cancer Chemother Pharmacol, 2000,46( 1 ) : 19-26.
  • 5Guo P, Wang X, Liu L, et al. Determination of methotrexate and its major metabolite 7-hydroxymethotrexate in mouse plasma and brain tissue by liquid chromatography-tandem mass spectrometry [J]. J Pharm Biomed Anal, 2007,43 (5) : 1789- 95.
  • 6Green M R, Chowdhary S, Lombardi K M, et al. Clinical utility and pharmacology of high-dose methotrexate in the treatment of primary CNS lymphoma [J]. Expert Rev Neurother, 2006,6(5) :635-652.
  • 7Vassal G, Vaheau D, Bonnay M, et al. Cerebrospinal fluid and plasma methotrexate levels following high-dose regimen given as a 3-hour intravenous infusion in children with non-Hodgkin's lymphoma [J]. Pediatr Hematol Oncol, 1990,7(1) :71-77.
  • 8Millot F, Rubie H, Mazingue F, et al. Cerebrospinal fluid drug levels of leukemic children receiving intravenous 5 g/m2 methotrexate [J]. Leuk Lymphoma, 1994,14(1-2) : 141-144.
  • 9Milano G, Thyss A, Serre Debeauvais F, et al. CSF drug levels for children with acute lymphoblastic leukemia treated by 5 g/m^2 methotrexate. A study from the EORTC Children's Leukemia Cooperative Group [J]. Eur J Cancer, 1990,26(4): 492-495.
  • 10Seidel H, Andersen A, Kvalcy JT, et al. Variability in methotrexate serum and cerebrospinal fluid pharmacokinetics in children with acute lymphocytic leukemia: relation to assay methodology and physiological variables [J]. Leuk Res, 2000, 24(3) : 193-199.

共引文献45

同被引文献10

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部